Holen Sie sich die Stockscreener-App
13.49
3.30%
-0.46
Handel nachbörslich:
13.49
Cullinan Therapeutics Inc Aktie (CGEM) Neueste Nachrichten
Whale Trades: Can Cullinan Therapeutics Inc outperform under higher oil pricesDividend Hike & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE) - The Globe and Mail
Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Expected to Rise, Wedbush Analyst Says - MarketBeat
Cullinan Therapeutics (CGEM): Wedbush Raises Price Target to $36 - GuruFocus
CGEM: Key T-cell engager programs advance toward pivotal milestones and data readouts in 2026 - TradingView
Cullinan Therapeutics: Q4 Earnings InsightsCullinan Therapeutics (NASDAQ:CGEM) - Benzinga
Cullinan Oncology (CGEM) Projects Strong Cash Position into 2029 - GuruFocus
Cullinan Therapeutics Reports 2025 Financial Results, Updates on CLN-978, Zipalertinib NDA, and 2026 Clinical Milestones - Minichart
Cullinan Therapeutics Inc (CGEM) Reports Q4 Earnings - AlphaStreet
Stifel raises Cullinan Oncology stock price target on autoimmune progress - Investing.com
Cullinan Therapeutics (CGEM) Reports Q4 Loss of $0.77 Per Share, Flat Year-Over-Year - AlphaStreet
Cullinan Therapeutics 2025 10-K: Advancing First-in-Class Therapies for Autoimmune Diseases and Cancer, Risks, and Strategic Developments - Minichart
Cullinan Therapeutics 2025 Financial Report: Q4 Loss Beats EstimatesNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Cullinan Therapeutics (CGEM) Anticipates Major Developments thro - GuruFocus
Cullinan Therapeutics: Fourth Quarter Earnings Overview - Bitget
Earnings Flash (CGEM) Cullinan Therapeutics Posts Q4 Net Loss $0.77 a Share, vs. FactSet Est of $0.77 Loss - marketscreener.com
Cullinan Therapeutics (NASDAQ:CGEM) Releases Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Cullinan Therapeutics 10-K — $0 Revenue, Net Loss $219.9M - TradingView
Cullinan Therapeutics: Q4 Earnings Snapshot - kare11.com
Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 ... - Bluefield Daily Telegraph
BRIEF-Cullinan Therapeutics Q4 Operating Expenses USD 55.259 Million - TradingView
Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewswire
Jennifer Michaelson Sells 8,000 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat
Cullinan Therapeutics Maps 2026 Data Catalysts for Autoimmune CLN-978, AML CLN-049 at TD Cowen Conference - MarketBeat
Blue Owl Capital Holdings LP Has $14.89 Million Position in Cullinan Therapeutics, Inc. $CGEM - MarketBeat
What is Cullinan Therapeutics Incs valuation compared to sector2025 Biggest Moves & Precise Buy Zone Tips - baoquankhu1.vn
Can Cullinan Therapeutics Inc generate free cash flowWeekly Stock Recap & Smart Money Movement Tracker - baoquankhu1.vn
[SCHEDULE 13G] Cullinan Therapeutics, Inc. Passive Investment Disclosure (>5%) - Stock Titan
CGEM: Transformational milestones and pivotal data for autoimmune and AML programs expected by 2026 - TradingView
CGEM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Cullinan Therapeutics (CGEM) Stock Analysis: Exploring A 101% Upside Potential - DirectorsTalk Interviews
Cullinan Therapeutics (NASDAQ:CGEM) Shares Up 7.6%Here's Why - MarketBeat
Cullinan Therapeutics executives to join major healthcare conference fireside chats - Traders Union
Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $25,169.20 in Stock - MarketBeat
Insider Sell: Jennifer Michaelson Sells Shares of Cullinan Thera - GuruFocus
Cullinan Therapeutics (CGEM) CSO sells 1,780 shares in Rule 10b5-1 trade - Stock Titan
CGEM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cullinan Therapeutics (NASDAQ:CGEM) Insider Jennifer Michaelson Sells 1,752 Shares - MarketBeat
Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells 3,601 Shares of Stock - MarketBeat
Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $66,301.54 in Stock - MarketBeat
Cullinan Therapeutics (NASDAQ:CGEM) CEO Nadim Ahmed Sells 13,515 Shares - MarketBeat
Cullinan Therapeutics (CGEM) CSO sells 5,353 shares under 10b5-1 plan - Stock Titan
Cullinan Therapeutics (CGEM) CMO sells shares to cover RSU tax bill - Stock Titan
[Form 4] Cullinan Therapeutics, Inc. Insider Trading Activity - Stock Titan
Jennifer Michaelson sells shares under 10b5-1 (CGEM) - Stock Titan
Cullinan Therapeutics (NASDAQ:CGEM) Hits New 12-Month HighWhat's Next? - MarketBeat
Cullinan Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire
Cullinan Therapeutics: Thesis Strengthening For T-Cell Engager Specialist (NASDAQ:CGEM) - Seeking Alpha
Jennifer Michaelson Sells 11,742 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat
Cullinan Therapeutics (NASDAQ:CGEM) Insider Jeffrey Alan Jones Sells 4,982 Shares - MarketBeat
Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) CFO Sells 4,398 Shares of Stock - MarketBeat
Cullinan Therapeutics (CGEM) CMO sells 4,982 shares for RSU tax obligations - Stock Titan
Cullinan Therapeutics (CGEM) CSO exercises options and sells 11,742 shares - Stock Titan
Cullinan Therapeutics (CGEM) CLO sells 3,742 shares to cover tax - Stock Titan
Cullinan Therapeutics (CGEM) CEO sells shares to cover RSU tax bill - Stock Titan
Cullinan Therapeutics (CGEM) CFO sells shares to cover RSU tax bill - Stock Titan
CGEM (NASDAQ: CGEM) Form 144 shows 1,752-share proposed resale; insider sales listed - Stock Titan
Cullinan Therapeutics Inc expected to post a loss of 81 cents a shareEarnings Preview - TradingView
Is Cullinan Therapeutics Inc. benefiting from innovation trendsCEO Change & Detailed Earnings Play Strategies - mfd.ru
Cullinan Therapeutics (NASDAQ:CGEM) Cut to Hold at Zacks Research - Defense World
Cullinan Therapeutics (NASDAQ:CGEM) Stock Rating Lowered by Zacks Research - MarketBeat
Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: A Biotech With 120% Upside Potential - DirectorsTalk Interviews
Will Cullinan Therapeutics Inc. stock recover faster than peersJuly 2025 PreEarnings & Smart Money Movement Alerts - mfd.ru
What is the long term forecast for Cullinan Therapeutics Inc. stockJuly 2025 Sentiment & Detailed Earnings Play Alerts - mfd.ru
What is Cullinan Therapeutics Inc.’s valuation compared to sectorJuly 2025 Selloffs & Real-Time Stock Price Movement Reports - mfd.ru
Jennifer Michaelson proposes sale of 8,000 shares | CGEM SEC FilingForm 144 - Stock Titan
Cullinan Therapeutics (NASDAQ:CGEM) Research Coverage Started at Citigroup - Defense World
Cullinan Therapeutics Touts 2026 “Defining Year” as T-Cell Engager, Zipalertinib Catalysts Near - MarketBeat
Cullinan Therapeutics (NASDAQ:CGEM) Hits New 1-Year HighTime to Buy? - MarketBeat
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):